Chong Kun Dang, Top Search Ranking... Stock Price Up 0.28%
Jongkundang has ranked among the top searched stocks on 4 days within the past month.
As of 12:31 PM on the 5th, Jongkundang is trading at 179,000 KRW, up 0.28% from the previous day. This is a 21.66% decrease compared to January 14. Jongkundang is known as a leading pharmaceutical company in the industry, focusing on therapeutics.
Over the past 5 days, individual investors have net purchased 108,076 shares, while foreigners and institutions have net sold 58,605 shares and 47,833 shares, respectively.
On January 26, Jongkundang made headlines in the market with the news "Completion of Phase 2 Clinical Trial for COVID-19 Therapeutic... Second upon Approval."
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051414165763158_1778735817.jpg)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- [Breaking] Two Days Before Strike... Central Labor Relations Commission Chair Park Soogeun Says "Differences Narrowing... Possibility of Agreement"
- Individual Investors Absorb Foreign Sell-Off... Concerns Over Becoming "Cannon Fodder" Emerge
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
※Source: AI Investment Assistant AI Lassi
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
